4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-032137
Chief Financial Officer sold 27,071 shares at $22.00 ($595,562)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2019-05-21 | Sale | −27,071 | $22.00 | $595,562 | 278,536 | D |
| Open-market sales · 27,071 sh · avg $22.00 · $595,562 | |||||||
Loading xslF345X03/doc4.xml…